| Literature DB >> 27798618 |
Rui Martins1,2, Julia Maier1,2, Anna-Dorothea Gorki1,2, Kilian V M Huber1, Omar Sharif1,2, Philipp Starkl1,2, Simona Saluzzo1,2, Federica Quattrone1,2, Riem Gawish1,2, Karin Lakovits2, Michael C Aichinger3, Branka Radic-Sarikas1, Charles-Hugues Lardeau1, Anastasiya Hladik1,2, Ana Korosec1,2, Markus Brown4, Kari Vaahtomeri5, Michelle Duggan5, Dontscho Kerjaschki4, Harald Esterbauer6, Jacques Colinge1, Stephanie C Eisenbarth7, Thomas Decker3, Keiryn L Bennett1, Stefan Kubicek1, Michael Sixt5, Giulio Superti-Furga1,8, Sylvia Knapp1,2.
Abstract
Hemolysis drives susceptibility to bacterial infections and predicts poor outcome from sepsis. These detrimental effects are commonly considered to be a consequence of heme-iron serving as a nutrient for bacteria. We employed a Gram-negative sepsis model and found that elevated heme levels impaired the control of bacterial proliferation independently of heme-iron acquisition by pathogens. Heme strongly inhibited phagocytosis and the migration of human and mouse phagocytes by disrupting actin cytoskeletal dynamics via activation of the GTP-binding Rho family protein Cdc42 by the guanine nucleotide exchange factor DOCK8. A chemical screening approach revealed that quinine effectively prevented heme effects on the cytoskeleton, restored phagocytosis and improved survival in sepsis. These mechanistic insights provide potential therapeutic targets for patients with sepsis or hemolytic disorders.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27798618 DOI: 10.1038/ni.3590
Source DB: PubMed Journal: Nat Immunol ISSN: 1529-2908 Impact factor: 25.606